AI MARKET SCANNING

Immunic Inc

📅 Next Catalyst: Nov 13, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.42%
MAX GAP RECORD -5.98%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IMUX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 13, 2026 Earnings Release 2026-11-13 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 10, 2026 Earnings Release 2026-08-10 (BEFORE OPEN)
-0.49%
May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN)
-3.28%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
+1.54%
Nov 13, 2025 Earnings Release 2025-11-13 (BEFORE OPEN)
+2.63%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
-0.41%
Mar 31, 2025 Earnings Release 2025-03-31 (BEFORE OPEN)
-1.67%
Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN)
-0.85%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.0%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IMUX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗